Pegcetacoplan Safety: Panel Recap

Related

• 

  Dual Anti-platelet Therapy Decelerates the Progression of Geographic Atrophy Secondary to Age-Related Macular Degeneration

  Yodpong Chantarasorn, MD

  On Demand Cases, Courses, and Papers

  2021

• 

  GATHER2 Phase 3 Efficacy Results and GATHER2 Phase 3 Safety Results

  Jeffrey S. Heier, MD

  Arshad M. Khanani, MD, MA, FASRS

  Updates from the Field

  2022

• 

  Characterizing Real-World Functional Outcomes in Patients with Geographic Atrophy: An IRIS Registry Analysis

  Durga Borkar, MD

  Annual Meeting Talks

  2022